Such habitat-specific thermal limits may be widespread for tropical ectotherms and could affect species vulnerability to environmental change. However, microclimate and within-generation developmental processes (e.g. plasticity) will mediate these differences, and determining the fitness consequences of thermal variation for ecotone and rainforest species will require continued study of both within-generation and across-generation eco-evolutionary processes.This article has an associated First Person interview with the first author of the paper.To test whether StandingTall, a home based, e-health balance exercise programme delivered through an app, could provide an effective, self-managed fall prevention programme for community dwelling older people.
Assessor blinded, randomised controlled trial.
Older people living independently in the community in Sydney, Australia.
503 people aged 70 years and older who were independent in activities of daily living, without cognitive impairment, progressive neurological disease, or any other unstable or acute medical condition precluding exercise.
Participants were block randomised to an intervention group (two hours of StandingTall per week and health education; n=254) or a control group (health education; n=249) for two years.
The primary outcomes were the rate of falls (number of falls per person year) and the proportion of people who had a fall over 12 months. Secondary outcomes were the number of people who had a fall and the number who had an injurious fall (resulting in any injury or requiringicant effects at 12 months. E-health exercise programmes could provide promising scalable fall prevention strategies.
ACTRN12615000138583.
ACTRN12615000138583.Emergence of novel coronavirus-2019 has become an international health concern. The objective of this review is to focus on 2019-nCoV emergence, prophylaxis and to predict the treatment approaches. The first case of 2019-nCoV was noted in Wuhan, China. The WHO has announced this epidemic as pandemic. The 2019-nCoV has +ve ssRNA (29903bp), lipid-bilayer envelope spiked with glycoprotein and bears genome sequences similar to bat coronavirus RaTG13. Antiviral agents like Interferon, Darunavir, Ribavirin, Lopinavir, Remdesivir, Chloroquine and Camostat mesylate may be considered for clinical trials. Chinese herbals may be effective against 2019-nCoV. These include Saikosaponins (triterpene glycosides), Amentoflavone, Scutellarein, Myricetin, extracts of Isatis indigotica, and Houttuynia cordata. Another treatment approach is to administer plasma from COVID-19 recovered patients. RNA vaccines, recombinant vector based vaccine and ACE-2 receptor like molecules may be employed for immunization against COVID-19. Moreover, immunity can be boosted against 2019-nCoV by regular exercise. We have checked Thymoquinone as ligand for various targets of 2019-nCoV (receptor binding domain of spike, RNA polymerase, protease, Nsp9 RNA binding protein, nucleocapsid phosphoprotein, endoribonuclease) by protein-ligand docking server SwissDoc. Thymoquinone can bind effectively to the targets of 2019-nCoV. Hence, it may be an effective candidate for the treatment of COVID-19.Respiratory infectious diseases had happened in China in recent years, and the outbreak of Corona Virus Disease 2019(COVID-19) had drawn worldwide attention. In order to control such high-mortality infectious diseases, the work of the Chinese government and the medical community in detection reagents, drugs, and vaccines had been speeded up. This research extensively searched the medical data of drugs, vaccines and kits development, the company's business report and the government's policy documents and conducted case analysis. We found some national mobilization measures had been put on the agenda and some special marketing authorization measures had been adopted. Due to the limitations of biotechnology research and the pharmaceutical industry, some key technologies and drugs still had a high external dependence. In the process of development, it was necessary to attach importance to scientific, ethical, and safety construction, and to strengthen international cooperation.With the emergence of COVID-19 (Corona virus Disease 19), the workers tried to search the drug/s for its management. Chloroquine, hydroxychloroquine and protease inhibitors including Ritonavir have been tested. But the safety and efficacy of these drugs for the treatment of COVID-19 were not very strong. Fusion inhibitors may be used for the management or prophylaxis of viral diseases. Objective of the present study was to design a fusion inhibitor for specific management of COVID-19. A series of BLAST was performed to get an optimized and conservative region of the spike protein of the virus which is used in fusion process. Based on the recent data available, residue 1160-1189 of spike protein of Novel coronavirus-2019 (2019-nCoV) was found highly conserved region with 100% similarity, with maximum score of 99.5 and with an E-value of 5e-24. Thus, this sequence was selected as a drug. This drug is a synthetic peptide composed of 30 amino acids of Heptad Repeat 2 (HR2) region of spike protein of 2019-nCoV and was named as QadirVID-19 (Qadir, name of the scientist who developed it and VID-19 from COVID-19).Novel coronavirus disease (COVID-19) has become a pandemic threat to public health. Vaccines and targeted therapeutics to prevent infections and stop virus proliferation are currently lacking. https://www.selleckchem.com/products/bicuculline.html Endoribonuclease Nsp15 plays a vital role in the life cycle, including replication and transcription as well as virulence of the virus. Here, we investigated Vitamin D for its in silico potential inhibition of the binding sites of SARS-CoV-2 endoribonuclease Nsp15. In this study, we selected Remdesivir, Chloroquine, Hydroxychloroquine and Vitamin D to study the potential binding affinity with the putative binding sites of endoribonuclease Nsp15 of COVID-19. The docking study was applied to rationalize the possible interactions of the target compounds with the active site of endoribonuclease Nsp 15. Among the results, Vitamin D was found to have the highest potency with strongest interaction in terms of LBE, lowest RMSD, and lowest inhibition intensity Ki than the other standard compounds. The investigation results of endoribonuclease Nsp15 on the PrankWeb server showed that there are three prospective binding sites with the ligands.